Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
15 studies found for:    pemphigoid | Open Studies
Show Display Options
RSS Create an RSS feed from your search for:
pemphigoid | Open Studies
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Download search resultsDownload the search results for:
pemphigoid | Open Studies (15 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting Observational Study Assessing Outcomes, Treatment Patterns and Related Costs in Patients in Bullous Pemphigoid
Condition: Bullous Pemphigoid
Interventions: Drug: treatment with topical superpotent corticosteroid therapy;   Drug: treatment with systemic therapy (methotrexate);   Drug: treatment systemic therapy (prednisone);   Drug: treatment with systemic therapy (prednisone);   Drug: treatment with systemic therapy (doxycycline)
2 Recruiting Genetic Susceptibility and Influence of the Microbiomae in Bullous Pemphigoid
Condition: Bullous Pemphigoid
Intervention: Other: Blood sample and cotton skin swabs
3 Recruiting Pruritus and Pemphigoid in Nursing Home Patients
Conditions: Pemphigoid;   Pruritus
Intervention: Other: Blood sample
4 Recruiting Anti-IL-5 Therapy in Bullous Pemphigoid (BP)
Condition: Pemphigoid, Bullous
Interventions: Drug: Mepolizumab (a-IL-5 antibody);   Drug: Placebo
5 Recruiting Evaluation of Safety, Efficacy and Pharmacodynamic Effect of Bertilimumab in Patients With Bullous Pemphigoid
Condition: Pemphigoid, Bullous
Intervention: Biological: Bertilimumab
6 Recruiting Evaluation of Fluid Retention Due to Superpotent Topical Corticosteroid
Condition: Bullous Pemphigoid
Interventions: Procedure: Impedance analysis;   Drug: Clobetasol Propionate cream treatment
7 Recruiting Role of Proteasomes in a Dermatological Autoimmune Disease: Bullous Pemphigoid
Conditions: Pemphigoid, Bullous;   Pemphigus;   Lupus Erythematosus, Cutaneous
Intervention:
8 Recruiting Autoimmune Blistering Diseases Study
Conditions: Pemphigus Vulgaris;   Pemphigus Foliaceus;   Bullous Pemphigoid
Intervention: Other: Questionnaires
9 Available Clinical Trial on the Effect of Autologous Oral Mucosal Epithelial Sheet Transplantation
Conditions: Limbal Stem Cell Deficiency;   Stevens-johnson Syndrome;   Ocular Cicatricial Pemphigoid;   Chemical Burn
Intervention: Biological: cultivated oral mucosal epithelial sheet transplantation
10 Recruiting Identification of Vulnerability Factors in the Course of Pemphigus Patients
Conditions: Pemphigus;   Dermatological Disease
Intervention: Behavioral: psychological support and therapeutic education program
11 Recruiting Register of Autoimmune Bullous Dermatoses
Condition: Autoimmune Bullous Dermatoses
Intervention: Other: Data collection
12 Recruiting Safety, Tolerability and Activity of TNT009 in Healthy Volunteers and Patients With Complement Mediated Disorders
Conditions: Bullous Pemphigoid (BP);   Cold Agglutinin Disease;   Warm Autoimmune Hemolytic Anemia;   End-stage Renal Disease (ESRD)
Interventions: Drug: TNT009;   Other: Placebo
13 Recruiting Limbal Epithelial Stem Cell Transplantation: a Phase II Multicenter Trial
Condition: Limbal Stem Cell Deficiency
Intervention: Biological: Limbal epithelial stem cell graft
14 Not yet recruiting Serum FFA Desaturase Activity Index in Patients on High Dose Corticosteroids
Condition: Glucocorticoid
Intervention: Drug: Prednisone
15 Recruiting Use of Cross-linked Donor Corneas as Carriers for the Boston Keratoprosthesis
Conditions: Chemical Injuries;   Unspecified Complication of Corneal Transplant;   Autoimmune Diseases;   Ocular Cicatricial Pemphigoid;   Stevens Johnson Syndrome;   Lupus Erythematosus, Systemic;   Rheumatoid Arthritis;   Other Autoimmune Diseases
Intervention: Drug: Riboflavin

Study has passed its completion date and status has not been verified in more than two years.